🇺🇸 FDA
Patent

US 10874719

Nucleotide phosphate dissipation as a treatment for vascular disorders

granted A61KA61K38/465

Quick answer

US patent 10874719 (Nucleotide phosphate dissipation as a treatment for vascular disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/465